- Home
- SNGX vs VEEE Comparison
SNGX vs VEEE Comparison
Compare SNGX & VEEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNGX
- VEEE
- Stock Information
- Founded
- SNGX 1987
- VEEE 1994
- Country
- SNGX United States
- VEEE United States
- Employees
- SNGX N/A
- VEEE N/A
- Industry
- SNGX Biotechnology: Pharmaceutical Preparations
- VEEE Marine Transportation
- Sector
- SNGX Health Care
- VEEE Industrials
- Exchange
- SNGX Nasdaq
- VEEE Nasdaq
- Market Cap
- SNGX 6.5M
- VEEE 6.4M
- IPO Year
- SNGX 1987
- VEEE 2021
- Fundamental
- Price
- SNGX $1.93
- VEEE $2.46
- Analyst Decision
- SNGX
- VEEE
- Analyst Count
- SNGX 0
- VEEE 0
- Target Price
- SNGX N/A
- VEEE N/A
- AVG Volume (30 Days)
- SNGX 18.1K
- VEEE 1.1M
- Earning Date
- SNGX 05-09-2025
- VEEE 05-08-2025
- Dividend Yield
- SNGX N/A
- VEEE N/A
- EPS Growth
- SNGX N/A
- VEEE N/A
- EPS
- SNGX N/A
- VEEE N/A
- Revenue
- SNGX $2,342.00
- VEEE $12,724,465.00
- Revenue This Year
- SNGX N/A
- VEEE N/A
- Revenue Next Year
- SNGX N/A
- VEEE N/A
- P/E Ratio
- SNGX N/A
- VEEE N/A
- Revenue Growth
- SNGX N/A
- VEEE N/A
- 52 Week Low
- SNGX $1.68
- VEEE $2.05
- 52 Week High
- SNGX $14.83
- VEEE $9.30
- Technical
- Relative Strength Index (RSI)
- SNGX 49.95
- VEEE 48.05
- Support Level
- SNGX $1.86
- VEEE $2.13
- Resistance Level
- SNGX $1.97
- VEEE $2.35
- Average True Range (ATR)
- SNGX 0.09
- VEEE 0.17
- MACD
- SNGX 0.01
- VEEE 0.00
- Stochastic Oscillator
- SNGX 70.59
- VEEE 44.59
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
About VEEE Twin Vee PowerCats Co.
Twin Vee PowerCats Co is a designer, manufacturer, and marketer of recreational and commercial power catamaran boats to use for fishing, diving and water skiing and commercial activities including transportation, eco-tours, fishing, and diving expeditions. Its revenue is derived from the sale of boats, motors, and trailers to its independent dealers. It has organized its business into three operating segments: The gas-powered boat segment, which manufactures and distributes gas-powered boats; The electric-powered boat segment, which is developing fully electric boats, through its controlling interest subsidiary, and its franchise segment, which is developing a standard product offering and will be selling franchises across the United States through its wholly-owned subsidiary.